Information:
Error:
ID
15129
Description
Process Versus Outcomes Incentives for Lipid Management; ODM derived from: https://clinicaltrials.gov/show/NCT02246959
Link
https://clinicaltrials.gov/show/NCT02246959
Keywords
Versions (1)
- 5/17/16 5/17/16 -
Uploaded on
May 17, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT02246959
Eligibility Diabetes NCT02246959
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT02246959
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Diabetes | Cardiovascular Diseases | Myocardial Infarction | Cerebrovascular accident | Peripheral Vascular Diseases
Item
diabetes and/or history of cvd (defined as diagnosis with myocardial infarction, stroke, or peripheral vascular disease)
boolean
C0011847 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0085096 (UMLS CUI [5])
C0007222 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0085096 (UMLS CUI [5])
Low density lipoprotein cholesterol measurement
Item
ldl greater than or equal to 130 mg/dl measured during screening of potential participants
boolean
C0202117 (UMLS CUI [1])
Hydroxymethylglutaryl-CoA Reductase Inhibitors Pharmaceutical Preparations
Item
a prescription filled for a statin medication within the last 12 months (derived from pharmacy records)
boolean
C0360714 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Possession of drugs Ratio
Item
medication possession ratio (mpr) less than 80%.
boolean
C0556451 (UMLS CUI [1,1])
C0456603 (UMLS CUI [1,2])
C0456603 (UMLS CUI [1,2])
Age
Item
under 18 years old
boolean
C0001779 (UMLS CUI [1])
Medical contraindication Use of Hydroxymethylglutaryl-CoA Reductase Inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors Adverse effects | Myopathy
Item
a contraindication to further statin use or have suffered statin side effects, such as myopathy
boolean
C1301624 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0360714 (UMLS CUI [1,3])
C0360714 (UMLS CUI [2,1])
C0879626 (UMLS CUI [2,2])
C0026848 (UMLS CUI [3])
C1524063 (UMLS CUI [1,2])
C0360714 (UMLS CUI [1,3])
C0360714 (UMLS CUI [2,1])
C0879626 (UMLS CUI [2,2])
C0026848 (UMLS CUI [3])
Unwilling Informed Consent
Item
will not or cannot give consent
boolean
C0558080 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
Liver diseases | Liver function tests abnormal | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
a history of active liver disease or abnormal liver function tests on baseline screening [alanine aminotransferase (alt) or aspartate aminotransferase (ast) greater than 3x the upper limit of normal].
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0151766 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
Study Subject Participation Status
Item
participating in another clinical trial with related aims
boolean
C2348568 (UMLS CUI [1])
Comorbidity Life Threatening | Neoplasm Metastasis
Item
co-morbidities likely to lead to death within a short period (e.g. metastatic cancer)
boolean
C0009488 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])
C2826244 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])